About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Understanding the Delay in Clinical Efficacy of Antidepressant Action

by Bidita Debnath on October 12, 2016 at 11:07 PM
Font : A-A+

 Understanding the Delay in Clinical Efficacy of Antidepressant Action

Depression is a mental illness that affects how a person feels, thinks and handles daily activities. To alleviate the symptoms of depression and help the brain process and use certain chemicals that regulate mood or stress, antidepressants are prescribed.

Unfortunately, existing medications usually require two to four weeks of use before patients respond. In a recent Paper of the Week in the Journal of Biological Chemistry, Mark M. Rasenick and his team at the University of Illinois at Chicago describe why antidepressants have a delayed impact.

Advertisement


One consistent finding in brain and some peripheral cells of patients who suffer depression is depletion of cyclic adenosine monophosphate, or cAMP. cAMP is a second messenger. Regular antidepressant treatment activates signaling pathways to cause an increase in accumulation of cAMP and transcription of cAMP-regulated genes, which include genes for neurotransmitters and growth factors, to alleviate the symptoms of depression.

Antidepressants work to increase the brain's concentrations of various neurotransmitters, such as norepinephrine, dopamine, noradrenaline, adrenaline and serotonin. Researchers suggest that the antidepressants' effects may be mediated through induction of the system that generates cAMP. But they need to understand why there is a delay in clinical efficacy of antidepressant action.
Advertisement

Rasenick and his team used glioma cells that lacked the monoamine transport proteins, including serotonin reuptake transport proteins, which are one of the binding sites for many antidepressants. They demonstrated that in the absence of SERT, antidepressants accumulate gradually in the plasma membrane microdomains of glioma cells. Next, Rasenick and colleagues showed that a sustained treatment with an antidepressant drug called escitalopram, better known by brand names of Lexapro and Cipralex, translocated the G-protein Gαs from lipid rafts. Lipid rafts are specialized regions of the plasma membrane that have been shown to inhibit the cAMP-generating cascade. Gαs went from lipid rafts to nonraft regions of the plasma membrane in the glioma cells, which enhanced its signaling ability.

Source: Newswise
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Sugar Intake and Oral Health
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Adolescence Depression Antidepressants Antidepressants Use during Pregnancy 

Most Popular on Medindia

A-Z Drug Brands in India Drug - Food Interactions Iron Intake Calculator Selfie Addiction Calculator Noscaphene (Noscapine) Pregnancy Confirmation Calculator Find a Hospital Calculate Ideal Weight for Infants Vent Forte (Theophylline) Blood Pressure Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Understanding the Delay in Clinical Efficacy of Antidepressant Action Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests